Manufacturing Capabilities
MS Pharma has an established track record of manufacturing across a wide range of dosage forms. All our manufacturing sites are GMP accredited.
MS Pharma’s Global Production Network Comprises 4 Sites:
- Algeria: MS Pharma’s manufacturing site in Algeria, operated by its subsidiary El Kendi, is the largest pharmaceutical production facility in the country. It serves as a center for the development and manufacturing of solid dose, liquid, and cream formulations, covering both over-the-counter (OTC) and prescription (Rx) products.
In 2025, a new manufacturing unit was added to the site, dedicated specifically to the production of oncological treatments. This unit supports the local availability of cancer therapies and expands the site’s production capabilities in specialized pharmaceuticals.
- Jordan, Steriles: Our sterile site in Jordan has capability in asceptic, terminal, and lyophilized vial production, Large volume parenteral, and Pre filled syringe production. It is the only such site in the country.
- Jordan, Non-Steriles: Our non-sterile manufacturing site has a range of capabilities. It is a development and manufacturing site for solid dose, cephalosporins, liquids, creams, soft gelatine capsules, and solid dose products.
- Saudi Arabia: MS Pharma operates two manufacturing sites in Saudi Arabia.
- The first is a full manufacturing facility for oral solids, with additional lines for secondary packaging for various dosage forms.
- The second facility is a newly launched, first-of-its-kind biologics facility in KSA and the region, designed for end-to-end production, including formulation, fill and finish, lyophilization, and packaging. It is capable of handling liquid vials, freeze-dried vials, cartridges, and prefilled syringes or pens. The site is equipped to produce complex biologic products such as monoclonal antibodies and peptides, meeting international regulatory standards.
- Both facilities are GMP certified by the Saudi Food and Drug Authority (SFDA).
Our Manufacturing Capabilities Include a Variety of Dosage Forms:
- Tablets, capsules, and oral dispersible manufacturing and packaging
- High potency tablets and capsules
- Sterile aseptic solution vials
- Freeze-dried vials
- LVP’s and Ampoules
- Sterile high potency vials
- Semi solids and liquids
- Soft gelatin capsules
- Multi-layer tablets
- Cephalosporins
- Shampoos
- Creams and liquids
MS Pharma’s dedicated R&D team has significant experience in formulation and analytical development, process development, and scale-up of various dosage forms.
MS Pharma has manufacturing sites in five countries in the MENA region and Europe.
